Endo International (NASDAQ:ENDP) (TSE:ENL) was downgraded by investment analysts at BidaskClub from a “buy” rating to a “hold” rating in a report released on Wednesday.

A number of other research firms have also recently commented on ENDP. Leerink Swann cut Endo International from an “outperform” rating to a “market perform” rating in a report on Tuesday, March 5th. Svb Leerink cut Endo International from an “outperform” rating to a “market perform” rating in a report on Tuesday, March 5th. ValuEngine upgraded Endo International from a “sell” rating to a “hold” rating in a report on Tuesday, March 12th. Zacks Investment Research upgraded Endo International from a “hold” rating to a “strong-buy” rating and set a $11.00 price target for the company in a report on Wednesday, January 9th. Finally, Piper Jaffray Companies restated a “hold” rating on shares of Endo International in a report on Friday, March 1st. Sixteen equities research analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. The stock presently has an average rating of “Hold” and a consensus price target of $15.44.

Endo International stock opened at $8.01 on Wednesday. Endo International has a 52 week low of $5.27 and a 52 week high of $18.50. The stock has a market cap of $1.83 billion, a P/E ratio of 2.82 and a beta of 1.21.

Endo International (NASDAQ:ENDP) (TSE:ENL) last posted its quarterly earnings results on Thursday, February 28th. The company reported $0.75 EPS for the quarter, topping analysts’ consensus estimates of $0.59 by $0.16. Endo International had a negative return on equity of 337.13% and a negative net margin of 35.00%. During the same quarter in the previous year, the company earned $0.77 earnings per share. On average, analysts forecast that Endo International will post 2.17 EPS for the current fiscal year.

Several large investors have recently modified their holdings of ENDP. LS Investment Advisors LLC acquired a new stake in shares of Endo International in the fourth quarter valued at approximately $59,000. Oregon Public Employees Retirement Fund acquired a new stake in shares of Endo International in the fourth quarter valued at approximately $76,000. First Quadrant L P CA acquired a new stake in shares of Endo International in the fourth quarter valued at approximately $92,000. Neuburgh Advisers LLC raised its position in shares of Endo International by 13.9% in the fourth quarter. Neuburgh Advisers LLC now owns 24,860 shares of the company’s stock valued at $181,000 after buying an additional 3,036 shares in the last quarter. Finally, Neuberger Berman Group LLC acquired a new stake in shares of Endo International in the third quarter valued at approximately $202,000. Institutional investors own 95.70% of the company’s stock.

About Endo International

Endo International plc, a specialty pharmaceutical company, manufactures and sells generic and branded pharmaceuticals in the United States, Canada, and internationally. The company operates through three segments: U.S. Generic Pharmaceuticals, U.S. Branded Pharmaceuticals, and International Pharmaceuticals.

Featured Story: How are Outstanding Shares Different from Authorized Shares?

Analyst Recommendations for Endo International (NASDAQ:ENDP)

Receive News & Ratings for Endo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Endo International and related companies with MarketBeat.com's FREE daily email newsletter.